AdvanSource Biomaterials Announces Patent for Antimicrobial Polyurethane Resins
8/25/2010 10:34:35 AM
WILMINGTON, Mass.--(BUSINESS WIRE)--AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a “Notice of Allowance” from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled “Antimicrobial Polyurethane Resins and Products Made Therefrom,” covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus (“MRSA”) clinical infections associated with medical devices.